Vote for your favorite mineral in #MinCup25! - Baryte vs. Hematite
It's a heavyweight match between industrial powerhouses as soft #baryte competes against rusty red #hematite.
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2019) Alirocumab/evolocumab. Reactions Weekly, 1736 (1) 21 doi:10.1007/s40278-019-56916-9

Advanced
   -   Only viewable:
Reference TypeJournal (article/letter/editorial)
TitleAlirocumab/evolocumab
JournalReactions Weekly
Year2019 (January)Volume1736
Issue1
PublisherSpringer Science and Business Media LLC
DOIdoi:10.1007/s40278-019-56916-9Search in ResearchGate
Generate Citation Formats
Mindat Ref. ID13378432Long-form Identifiermindat:1:5:13378432:1
GUID0
Full Reference(2019) Alirocumab/evolocumab. Reactions Weekly, 1736 (1) 21 doi:10.1007/s40278-019-56916-9
Plain Text(2019) Alirocumab/evolocumab. Reactions Weekly, 1736 (1) 21 doi:10.1007/s40278-019-56916-9
In(2019, January) Reactions Weekly Vol. 1736 (1) Springer Science and Business Media LLC

See Also

These are possibly similar items as determined by title/reference text matching only.

(2019) Alirocumab. Reactions Weekly, 1745 (1) 21 doi:10.1007/s40278-019-59184-9
(2018) Alirocumab/evolocumab. Reactions Weekly, 1728 (1) 22 doi:10.1007/s40278-018-54285-1
(2018) Alirocumab/evolocumab. Reactions Weekly, 1698 (1) 25 doi:10.1007/s40278-018-44969-6
(2018) Alirocumab/evolocumab. Reactions Weekly, 1712 (1) 42 doi:10.1007/s40278-018-49331-6
(2021) Alirocumab/evolocumab. Reactions Weekly, 1876 (1) 25 doi:10.1007/s40278-021-03274-2
(2021) Alirocumab, evolocumab: risk of neuropsychiatric ADRs. Reactions Weekly, 1837 (1) 7 doi:10.1007/s40278-021-88606-6
(2018) Muscle-related complaints with alirocumab and evolocumab. Reactions Weekly, 1721 (1) 2 doi:10.1007/s40278-018-52039-3
(2019) Evolocumab. Reactions Weekly, 1774 (1) 135 doi:10.1007/s40278-019-68581-0
(2019) Evolocumab. Reactions Weekly, 1780 (1) 161 doi:10.1007/s40278-019-71652-5
(2019) Evolocumab. Reactions Weekly, 1751 (1) 160 doi:10.1007/s40278-019-61293-0
(2019) Adalimumab. Reactions Weekly, 1736 (1) 16 doi:10.1007/s40278-019-56911-9
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are Β© OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: September 19, 2025 10:49:10
Go to top of page